Aligos Therapeutics, Inc. (ALGS)
NASDAQ·Healthcare·Biotechnology
$4.70
+1.08%
Mkt Cap $43.23M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$20.00
Range $20.00 – $20.00
Implied Upside
+325.5%
Consensus $20.00 vs current $4.70
NASDAQ·Healthcare·Biotechnology
$4.70
+1.08%
Mkt Cap $43.23M
No recent rating data.
Price Target (4 analysts)
$20.00
Range $20.00 – $20.00
+325.5%
Consensus $20.00 vs current $4.70